![Jonathan Sporn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jonathan Sporn
Fondatore presso Gilgamesh Pharmaceuticals, Inc.
Posizioni attive di Jonathan Sporn
Società | Posizione | Inizio | Fine |
---|---|---|---|
Gilgamesh Pharmaceuticals, Inc.
![]() Gilgamesh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gilgamesh Pharmaceuticals, Inc. engages in the development of drugs for the treatment of neuropsychiatric conditions including depression, anxiety, substance use, and stress-related disorders. Its products pipeline include Arylcyclohexylamine, Serotonergic Micro-Dose, and Novel Ibogaine Analogue. The company was founded by Jonathan Sporn, Dalibor Sames, Andrew Kruegel, Jeff Witkin, and Mike Cunningham and is headquartered in New York, NY. | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | - | - | |
Fondatore | - | - | |
Presidente | - | - |
Storia della carriera di Jonathan Sporn
Precedenti posizioni note di Jonathan Sporn
Società | Posizione | Inizio | Fine |
---|---|---|---|
Perception Neuroscience, Inc.
![]() Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Perception Neuroscience, Inc. operates as a biopharmaceutical company, focusing on developing therapies in Neuropsychiatry. The company was founded by Jonathan Sporn and Jay Kranzler and is headquartered in New York, NY. | Fondatore | - | - |
Statistiche
Distribuzione geografica
Stati Uniti | 3 |
Posizioni
Founder | 2 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Settori
Health Services | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Perception Neuroscience, Inc.
![]() Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Perception Neuroscience, Inc. operates as a biopharmaceutical company, focusing on developing therapies in Neuropsychiatry. The company was founded by Jonathan Sporn and Jay Kranzler and is headquartered in New York, NY. | Health Services |
Gilgamesh Pharmaceuticals, Inc.
![]() Gilgamesh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gilgamesh Pharmaceuticals, Inc. engages in the development of drugs for the treatment of neuropsychiatric conditions including depression, anxiety, substance use, and stress-related disorders. Its products pipeline include Arylcyclohexylamine, Serotonergic Micro-Dose, and Novel Ibogaine Analogue. The company was founded by Jonathan Sporn, Dalibor Sames, Andrew Kruegel, Jeff Witkin, and Mike Cunningham and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Jonathan Sporn
- Esperienza